Making a heartfelt difference through ESG excellence. Read WELL’s Inaugural (2021) ESG ReportRead WELL’s Inaugural (2021) ESG Report.

WELL Health Welcomes Sybil Lau to its Board of Directors and Announces Conference Call for Second Quarter 2022 Financial Results

Vancouver, BC, August 5, 2022 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) ("WELL" or the "Company"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the appointment of Sybil Lau to its board of directors.

Sybil Lau has 25 years of experience in both public and private investments. Born in Ottawa, Sybil received an undergraduate degree from Simon Fraser University. Sybil is a Director and on the Board of Directors of the Dalio Family Office in Singapore and is a Director and Board Director for a Chinese hedge fund. Earlier in her career, Sybil had founded and operated a China focused global consulting firm in Guangzhou, was an investment manager at Credit Suisse, and a financial analyst at Goldman Sachs. 

"We are honored to welcome Sybil Lau to our board," said Hamed Shahbazi, Chairman and CEO of WELL. “Her passion and focus on healthcare industries and preventative health overall are of tremendous value and interest to WELL and its future direction as a company.  Also, her knowledge and years of experience advising on capital allocation and new market development decisions will be an invaluable asset to the WELL team and our shareholders.”

Sybil is also highly involved in philanthropic work in South East Asia particularly in the areas of disability and vulnerable persons providing last mile and gap funding on health care initiatives. Sybil is fluent in French, English, Cantonese, and Mandarin.

WELL will also release its Second Quarter 2022 financial results for the period ended June 30, 2022 before market open on Thursday, August 11, 2022.  The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00 pm EST (10:00 am PST).  The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer and Eva Fong, Chief Financial Officer.  Please dial in 10 minutes prior to the start of the call.

Conference Call Participant Details

Date August 11, 2022
Time 1:00 PM ET / 10:00 AM PT
Confirmation # 9947 8397
Local Toronto: 416-764-8650
Vancouver:778-383-7413
North American Toll-Free  +1-888-664-6383
International +1-416-764-8650
Webcast URL https://www.well.company/for-investors/events/

WELL HEALTH TECHNOLOGIES CORP.

Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director         

About WELL Health Technologies Corp.

WELL is a practitioner focused digital healthcare company whose overarching objective is to positively impact health outcomes to empower and support healthcare practitioners and their patients. WELL has built an innovative practitioner enablement platform that includes comprehensive end to end practice management tools inclusive of virtual care and digital patient engagement capabilities as well as Electronic Medical Records (EMR), Revenue Cycle Management (RCM) and data protection services. WELL uses this platform to power healthcare practitioners both inside and outside of WELL's own omni-channel patient services offerings. As such, WELL owns and operates Canada's largest network of outpatient medical clinics serving primary and specialized healthcare services and is the provider of a leading multi-national, multi-disciplinary telehealth offering. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL" and on OTCQX under the symbol "WHTCF". To learn more about the Company, please visit: www.well.company.

For further information
Tyler Baba
Investor Relations Manager
investor@well.company
604-628-7266